Liposomal Formulations of a Polyleucine–Antigen Conjugate as Therapeutic Vaccines against Cervical Cancer

Human papilloma virus (HPV) is responsible for all cases of cervical cancer. While prophylactic vaccines are available, the development of peptide-based vaccines as a therapeutic strategy is still under investigation. In comparison with the traditional and currently used treatment strategies of chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Firdaus, Farrhana Z., Bartlett, Stacey, Hussein, Waleed M., Lu, Lantian, Wright, Quentin, Huang, Wenbin, Nahar, Ummey J., Yang, Jieru, Khongkow, Mattaka, Veitch, Margaret, Koirala, Prashamsa, Ruktanonchai, Uracha R., Monteiro, Michael J., Gonzalez Cruz, Jazmina L., Stephenson, Rachel J., Wells, James W., Toth, Istvan, Skwarczynski, Mariusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965676/
https://www.ncbi.nlm.nih.gov/pubmed/36839923
http://dx.doi.org/10.3390/pharmaceutics15020602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965676/
https://www.ncbi.nlm.nih.gov/pubmed/36839923
http://dx.doi.org/10.3390/pharmaceutics15020602

Ejemplares similares